Ras modifies proliferation and invasiveness of cells expressing human papillomavirus oncoproteins

Journal of Virology

Volumn 82, Issue 17, 2008, Pages 8820-8827

  Yoshida, Satoshi ^a   Kajitani, Naoko ^a   Satsuka, Ayano ^a   Nakamura, Hiroyasu ^a   Sakai, Hiroyuki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MATRIX METALLOPROTEINASE 14; PROTEIN E6; PROTEIN E7; RAS PROTEIN; VIRUS PROTEIN;

ARTICLE; CELL AGING; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WART VIRUS;

CELL AGING; CELL CULTURE TECHNIQUES; CELL LINE; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; FEMALE; GENETIC VECTORS; HELA CELLS; HUMAN PAPILLOMAVIRUS 18; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINOCYTES; KIDNEY; MALE; MUTATION; ONCOGENE PROTEINS, VIRAL; ORGAN CULTURE TECHNIQUES; PAPILLOMAVIRIDAE; RAS PROTEINS; RETINOBLASTOMA PROTEIN; RETROVIRIDAE; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 50149105888     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02363-07     Document Type: Article

References (59)

1. Akgül, B., R. García-Escudero, L. Ghali, H. J. Pfister, P. G. Fuchs, H. Navsaria, and A. Storey. 2005. The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin. Cancer Res. 65:2216-2223.
2. Alonio, L. V., M. A. Dalbert, D. Mural, J. Bartt, O. Kazán, G. Dominguez, and A. R. Teyssié. 2003. Ha-ras oncogene mutation associated to progression of papillomavirus induced lesions of uterine cervix. J. Clin. Virol. 27:263-269.
3. Bos, J. L. 1989. ras oncogenes in human cancer: a review. Cancer Res. 49:4682-4689.
4. Cairns, J. 1975. Mutation selection and the natural history of cancer. Nature 255:197-200.
5. Campisi, J., and F. d'Adda di Fagagna. 2007. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8:729-740.
6. Canty, E. G., and K. E. Kadler. 2005. Procollagen trafficking, processing and fibrillogenesis. J. Cell Sci. 118:1341-1353.
7. Cole, S. T., and O. Danos. 1987. Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. J. Mol. Biol. 193:599-608.
8. Coussens, L. M., C. L. Tinkle, D. Hanahan, and Z. Werb. 2000. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103:481-490.
9. Dollard, S. C., J. L. Wilson, L. M. Demeter, W. Bonnez, R. C. Reichman, T. R. Broker, and L. T. Chow. 1992. Production of human papillomavirus and modulation of the infectious program in epithelial raft cultures. Genes Dev. 6:1131-1142.
10. Downward, J. 2003. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3:11-22.
11. Duensing, S., A. Duensing, E. R. Flores, A. Do, P. F. Lambert, and K. Münger. 2001. Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytes. J. Virol. 75:7712-7716.
12. Dyson, N., P. M. Howley, K. Münger, and E. Harlow. 1989. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243:934-937.
13. Egeblad, M., and Z. Werb. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2:161-174.
14. Fehrmann, F., and L. A. Laimins. 2003. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene 22:5201-5207.
15. Flores, E. R., and P. F. Lambert. 1997. Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. J. Virol. 71:7167-7179.
16. Fridman, R., M. Toth, D. Pena, and S. Mobashery. 1995. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res. 55:2548-2555.
17. Gazel, A., T. Banno, R. Walsh, and M. Blumenberg. 2006. Inhibition of JNK promotes differentiation of epidermal keratinocytes. J. Biol. Chem. 281: 20530-20541.
18. Gonzalez, S. L., M. Stremlau, X. He, J. R. Basile, and K. Münger. 2001. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. J. Virol. 75:7583-7591.
19. Greenhalgh, D. A., X. J. Wang, J. A. Rothnagel, J. N. Eckhardt, M. I. Quintanilla, J. L. Barber, D. S. Bundman, M. A. Longley, R. Schlegel, and D. R. Roop. 1994. Transgenic mice expressing targeted HPV-18 E6 and E7 oncogenes in the epidermis develop verrucous lesions and spontaneous, Ha-ras-activated papillomas. Cell Growth Differ. 5:667-675.
20. Hahn, W. C., C. M. Counter, A. S. Lundberg, R. L. Beijersbergen, M. W. Brooks, and R. A. Weinberg. 1999. Creation of human tumour cells with defined genetic elements. Nature 400:464-468.
21. Harada, T., O. Matsuzaki, H. Hayashi, S. Sugano, A. Matsuda, and E. Nishida. 2003. AKRL1 and AKRL2 activate the JNK pathway. Genes Cells 8:493-500.
22. Heck, D. V., C. L. Yee, P. M. Howley, and K. Münger. 1992. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc. Natl. Acad. Sci. USA 89:4442-4446.
23. Helt, A. M., J. O. Funk, and D. A. Galloway. 2002. Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells. J. Virol. 76:10559-10568.
24. Hotary, K., E. Allen, A. Punturieri, I. Yana, and S. J. Weiss. 2000. Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J. Cell Biol. 149:1309-1323.
25. Howley, P. M., and D. Lowy. 2001 Papillomaviruses and their replication, p. 2197-2229. In D. M. Knipe and P. M. Howley (ed.), Fields virology, 4th ed. Lippincott Williams & Wilkins, Baltimore, MD.
26. Itoh, Y., and M. Seiki. 2006. MT1-MMP: a potent modifier of pericellular microenvironment. J. Cell Physiol. 206:1-8.
27. Jones, D. L., R. M. Alani, and K. Münger. 1997. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev. 11:2101-2111.
28. Kiyono, T., A. Hiraiwa, M. Fujita, Y. Hayashi, T. Akiyama, and M. Ishibashi. 1997. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. USA 94:11612-11616.
29. Klingelhutz, A. J., S. A. Foster, and J. K. McDougall. 1996. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380:79-82.
30. Kranenburg, O., M. F. Gebbink, and E. E. Voest. 2004. Stimulation of angiogenesis by Ras proteins. Biochim. Biophys. Acta 1654:23-37.
31. Lee, J. O., A. A. Russo, and N. P. Pavletich. 1998. Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7. Nature 391:859-865.
32. Lee, S. S., R. S. Weiss, and R. T. Javier. 1997. Binding of human virus oncoproteins to hD1g/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. USA 94:6670-6675.
33. Masson, V., L. R. de la Ballina, C. Munaut, B. Wielockx, M. Jost, C. Maillard, S. Blacher, K. Bajou, T. Itoh, S. Itohara, Z. Werb, C. Libert, J. M. Foidart, and A. Noël. 2005. Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes. FASEB J. 19:234-236.
34. Medína-Martinez, O., V. Vallejo, M. C. Guido, and A. García-Carrancá. 1997. Ha-ras oncogene-induced transcription of human papillomavirus type 18 E6 and E7 oncogenes. Mol. Carcinog. 19:83-90.
35. Meyers, C., M. G. Frattini, J. B. Hudson, and L. A. Laimins. 1992. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257:971-973.
36. Münger, K., A. Baldwin, K. M. Edwards, H. Hayakawa, C. L. Nguyen, M. Owens, M. Grace, and K. Huh. 2004. Mechanisms of human papillomavirus-induced oncogenesis. J. Virol. 78:11451-11460.
37. Münger, K., J. R. Basile, S. Duensing, A. Eichten, S. L. Gonzalez, M. Grace, and L. V. Zancy. 2001. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20:7888-7898.
38. Nguyen, M. L., M. M. Nguyen, D. Lee, A. E. Griep, and P. F. Lambert. 2003. The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J. Virol. 77:6957-6964.
39. O'Connor, M. J., W. Stünkel, C. H. Koh, H. Zimmermann, and H. U. Bernard. 2000. The differentiation-specific factor CDP/Cut represses transcription and replication of human papillomaviruses through a conserved silencing element. J. Virol. 74:401-410.
40. Pietenpol, J. A., R. W. Stein, E. Moran, P. Yaciuk, R. Schlegel, R. M. Lyons, M. R. Pittelkow, K. Münger, P. M. Howley, and H. L. Moses. 1990. TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61:777-785.
41. Pim, D., and L. Banks. 1991. Loss of HPV-16 E7 dependence in cells transformed by HPV-16 E7 plus EJ-ras correlates with increased c-myc expression. Oncogene 6:589-594.
42. Robinson, C. M., A. M. Stone, J. D. Shields, S. Huntley, I. C. Paterson, and S. S. Prime. 2003. Functional significance of MMP-2 and MMP-9 expression by human malignant oral keratinocyte cell lines. Arch. Oral Biol. 48:779-786.
43. Ruesch, M. N., F. Stubenrauch, and L. A. Laimins. 1998. Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin-10. J. Virol. 72:5016-5024.
44. Sagae, S., R. Kudo, N. Kuzumaki, T. Hisada, Y. Mugikura, T. Nihei, T. Takeda, and M. Hashimoto. 1990. Ras oncogene expression and progression in intraepithelial neoplasia of the uterine cervix. Cancer 66:295-301.
45. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
46. Schiffman, M., P. E. Castle, J. Jeronimo, A. C. Rodriguez, and S. Wacholder. 2007. Human papillomavirus and cervical cancer. Lancet 370:890-907.
47. Schreiber, K., R. E. Cannon, T. Karrison, G. Beck-Engeser, D. Huo, R. W. Tennant, H. Jensen, W. M. Kast, T. Krausz, S. C. Meredith, L. Chen, and H. Schreiber. 2004. Strong synergy between mutant ras and HPV16 E6/E7 in the development of primary tumors. Oncogene 23:3972-3979.
48. Schubbert, S., K. Shannon, and G. Bollag. 2007. Hyperactive Ras in developmental disorders and cancer. Nat. Rev. Cancer 7:295-308.
49. Serrano, M., A. W. Lin, M. E. McCurrach, D. Beach, and S. W. Lowe. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593-602.
50. Smola-Hess, S., J. Pahne, C. Mauch, P. Zigrino, H. Smola, and H. J. Pfister. 2005. Expression of membrane type 1 matrix metalloproteinase in papillomavirus-positive cells: role of the human papillomavirus (HPV) 16 and HPV8 E7 gene products. J. Gen. Virol. 86:1291-1296.
51. Taniwaki, K., H. Fukamachi, K. Komori, Y. Ohtake, T. Nonaka, T. Sakamoto, T. Shiomi, Y. Okada, T. Itoh, S. Itohara, M. Seiki, and I. Yana. 2007. Stroma-derived matrix metalloproteinase (MMP)-2 promotes membrane type 1-MMP-dependcnt tumor growth in mice. Cancer Res. 67:4311-4319.
52. Ueno, T., K. Sasaki, S. Yoshida, N. Kajitani, A. Satsuka, H. Nakamura, and H. Sakai. 2006. Molecular mechanisms of hyperplasia induction by human papillomavirus E7. Oncogene 25:4155-4164.
53. Werb, Z. 1997. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91:439-442.
54. Woodman, C. B., S. I. Collins, and L. S. Young. 2007. The natural history of cervical HPV infection: unresolved issues. Nat. Rev. Cancer 7:11-22.
55. Yokota, J., and T. Sugimura. 1993. Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes. FASEB J. 7:920-925.
56. Yukawa, K., K. Butz, T. Yasui, H. Kikutani, and F. Hoppe-Seyler. 1996. Regulation of human papillomavirus transcription by the differentiation-dependent epithelial factor Epoc-1/skn-1a. J. Virol. 70:10-16.
57. Zhai, Y., K. B. Hotary, B. Nan, F. X. Bosch, N. Muñoz, S. J. Weiss, and K. R. Cho. 2005. Expression of membrane type 1 matrix metalloproteinase is associated with cervical carcinoma progression and invasion. Cancer Res. 65:6543-6550.
58. Zhang, J. Y., C. L. Green, S. Tao, and P. A. Khavari. 2004. NF-κB RelA opposes epidermal proliferation driven by TNFR1 and JNK. Genes Dev. 1:17-22.
59. zur Hausen, H. 1996. Papillomavirus infections: a major cause of human cancers. Biochim. Biophys. Acta 1288:F55-F78.